members with critical insights, legislative updates, and additional advocacy efforts. Together, we will champion PBM reform, protect pharmacist provider status and defend patient access to cost effective medications at community pharmacies. LPG...
postmenopausal osteoporosis when alternative treatments are not suitable. Fresenius Kabi Calcitonin Salmon Injection is formulated, filled and packaged in the United States. Available in 400 I.U./2 mL (200 I.U./mL) vials, the new product adds to...
a foundation for long-term success. About KYZATREX® (testosterone undecanoate): KYZATREX is a proprietary softgel oral formulation absorbed primarily via the lymphatic system (meaning it is not toxic to the liver) and indicated in adult males for...
and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), announced the completion of the 10,000th case in the U.S. with the Match-the-Disc™ prodisc Cervical TDR...
treatments," said Robb Knie, CEO at Hoth Therapeutics. "We are committed to driving innovative solutions that can transform patient care." The study aligns with Hoth Therapeutics' mission to accelerate groundbreaking therapies and address unmet...
strategy, ensuring efficiency, and supply continuity as the company continues its strong trajectory of growth and transformation. “As we rapidly diversify our product portfolio and expand our footprint, we continue to enhance our operational...
Andrea Chadwick, Medical Director of Swing Care. “Incorporating innovative treatments like Stanza is a part of that transformation—and Highmark coverage puts it in reach for many more patients that could benefit.” About Swing Therapeutics: Swing...
suites for oral products (e.g., soft gels), an aseptic facility for injectables (e.g., vials, syringes, and cartridges), a formulation development center, and analytical and microbiology laboratories. This expertise will add a comprehensive...
Zafrens, a pioneering biotech company transforming drug discovery, welcomes imec.xpand to its Series A syndicate, bringing the total capital raised to USD 31 million. imec.xpand is joined by existing investors Prime Movers Lab, Kofa Healthcare,...
monoclonal antibody targeting TSLP, generated from the two heavy chains and two light chains (H2L2) Harbour Mice® platform. It inhibits the TSLP-mediated signaling pathway by blocking the interaction between TSLP and its receptor, which is a...
In doing so, we are redefining the future of orphan medicine commercialization and distribution across Europe. For more information, visit www.avanzanite.com.
acid sequence allowing for coverage of >80% of circulating HIV-1 viral variants. About HIV: HIV is one of the world’s most formidable public health challenges. It is estimated there are more than 38 million people living with HIV worldwide. The...
standard-of-care (SoC) and off-label drugs which are critical for treatment of drug-resistant cancers. DCG's advanced platform uses human-supervised AI to analyze high-resolution, real-time videos of tumor cells exposed to chemotherapy drugs. These...
our industry-leading brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, and Barkey. For more information, please visit www.azenta.com.
led by an experienced management team with a track record of developing and commercializing product candidates. For more information, please visit www.nlspharma.com. About Kadimastem: Kadimastem is a clinical stage cell therapy company, developing...
& Dashboarding, BD&L Support, KOL Profiling, Sales Force Analytics, and Predictive Analytics to help clients make informed and strategic decisions. Social Media Analytics - Social listening through patient and physician forums for Performance &...
launch of the Alto Automation Suite™ for its flagship Alto™ Digital SPR™ system. This makes Alto the world’s first SPR platform that is fully compatible with standard lab automation, enabling thousands of samples per week to be run without human...
assay kits on a custom Opentrons Flex® workstation. Scientists and engineers will collaborate to develop and verify platform workflows utilizing the broad offering of automation-enabled assays from the Life Science business of Merck KGaA,...
Syncona Limited, Forbion, Oxford Science Enterprises, TCGX, Advent Life Sciences and additional investors. Find more information please visit, www.beacontx.com.
leading to substantial discontinuation of patients' treatment in less than three months due to intolerable acneiform rashes. LUT014, a novel B-Raf inhibitor, is used for patients who develop dose-limiting rashes, potentially allowing them to...
